Related Experiment Videos
Drug-induced lupus and antiphospholipid syndrome associated with cysteamine therapy
Leah Krischock1, Catherine Horsfield, David D'Cruz
1Department of Paediatric Nephrology, Evelina Children's Hospital, St Thomas' Hospital, Westminster Bridge Road, London, UK. lkrischock@talktalk.net
Abstract:
Serological evidence of drug-induced lupus (DIL) and antiphospholipid syndrome (APS) were detected in a paediatric patient with nephropathic cystinosis during work-up for live related renal transplantation. Cysteamine was considered the most likely cause. Antinuclear (ANA) and antihistone antibodies disappeared after stopping cysteamine. ANA became positive after reintroduction of cysteamine. The patient's post-transplant course was complicated by severe thrombosis, with histological findings in her native nephrectomy consistent with APS. This is the first reported case of DIL and APS secondary to cysteamine therapy. Clinicians should exclude autoimmune abnormalities in patients with cystinosis, especially if patients report non-specific, unusual or unexplained symptoms.
Related Concept Videos
Hypersensitivity Reactions: Cytolytic Reactions
Drugs for Treatment of Ulcerative Colitis in IBD
Drug toxicity: Idiosyncratic Reactions
Nephrotic Syndrome I : Introduction
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Drugs for Treatment of Constipation-Predominant IBS